Relay Therapeutics is trading 5.33% up at $19.35 as technology shares lead a broad market rebound following strong corporate earnings and cooling inflation data.
- No company-specific announcements, earnings reports, or analyst actions were identified to explain the move.
- The stock appears to be benefiting from a broad risk-on tone across major U.S. indexes, bolstered by positive Microsoft results and a favorable macro environment.